Wnt receptors, bone mass, and fractures: Gene-wide association analysis of LRP5 and LRP6 polymorphisms with replication

European Journal of Endocrinology

Volumn 164, Issue 1, 2011, Pages 123-131

  Riancho, José A ^a   Olmos, José M ^a   Pineda, Begoña ^b   García Ibarbia, Carmen ^a   Pérez Núñez, María I ^a   Nan, Daniel N ^a   Velasco, Javier ^a   Cano, Antonio ^c   García Pérez, Miguel A ^b   Zarrabeitia, María T ^a   González Macías, Jesús ^a  

^a UNIVERSITY OF CANTABRIA   (Spain)

^b HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^c UNIVERSITY OF VALENCIA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

FRIZZLED PROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN 5; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN 6;

ADULT; AGED; ARTICLE; BODY HEIGHT; BONE DENSITY; BONE MASS; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; FEMUR NECK; GENE EXPRESSION; GENE REPLICATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC VARIABILITY; HIP FRACTURE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SPINE FRACTURE; VERTEBRA FRACTURE; AGE DISTRIBUTION; BONE LEVEL; FRAGILITY FRACTURE; GENE LOCATION; HUMAN TISSUE; MOLECULAR PATHOLOGY; POSTMENOPAUSE OSTEOPOROSIS;

AGED; AGED, 80 AND OVER; BONE DENSITY; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; DENSITOMETRY; FEMALE; FEMORAL NECK FRACTURES; FEMUR NECK; FRACTURES, BONE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LDL-RECEPTOR RELATED PROTEINS; MIDDLE AGED; ODDS RATIO; OSTEOPOROSIS, POSTMENOPAUSAL; POLYMORPHISM, SINGLE NUCLEOTIDE; POSTMENOPAUSE; SPINAL FRACTURES;

EID: 78751555838     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-10-0582     Document Type: Article

References (37)

1. Jeong YH, Sekiya M, HIrata M, Ye M, Yamagishi A, Lee SM, Kang MJ, Hosoda A, Fukumura T, Kim DH & Saeki S. The low-density lipoprotein receptor-related protein 10 is a negative regulator of the canonical Wnt/beta-catenin signaling pathway. Biochemical and Biophysical Research Communications 2010 392 495-499. (doi:10.1016/j.bbrc.2010.01.049)
2. Yadav VK, Ryu JH, Suda N, Tanaka KF, Gingrich JA, Schutz G, Glorieux FH, Chiang CY, Zajac JD, Insogna KL, Mann JJ, Hen R, Ducy P & Karsenty G. Lrp5 controls bone formation by inhibiting serotonin synthesis in the duodenum. Cell 2008 135 825-837. (doi:10.1016/j.cell.2008.09.059)
3. Holmen SL, Giambernardi TA, Zylstra CR, Buckner-Berghuis BD, Resau JH, Hess JF, Glatt V, Bouxsein ML, Ai M, Warman ML & Williams BO. Decreased BMD and limb deformities in mice carrying mutations in both Lrp5 and Lrp6. Journal of Bone and Mineral Research 2004 19 2033-2040. (doi:10.1359/jbmr.040907)
4. Zylstra CR, Wan C, VanKoevering KK, Sanders AK, Lindvall C, Clemens TL & Williams BO. Gene targeting approaches in mice: assessing the roles of LRP5 and LRP6 in osteoblasts. Journal of Musculoskeletal & Neuronal Interactions 2008 8 291-293.
5. Sims AM, Shephard N, Carter K, Doan T, Dowling A, Duncan EL, Eisman J, Jones G, Nicholson G, Prince R, Seeman E, Thomas G, Wass JA & Brown MA. Genetic analyses in a sample of individuals with high or low bone density demonstrates association with multiple Wnt pathway genes. Journal of Bone and Mineral Research 2008 23 499-506. (doi:10.1359/jbmr.071113)
6. van Meurs JB, Rivadeneira F, Jhamai M, Hugens W, Hofman A, van Leeuwen JP, Pols HA & Uitterlinden AG. Common genetic variation of the low-density lipoprotein receptor-related protein 5 and 6 genes determines fracture risk in elderly white men. Journal of Bone and Mineral Research 2006 21 141-150. (doi:10.1359/JBMR.050904)
7. Mencej-Bedrac S, Prezelj J, Kocjan T, Komadina R & Marc J. Analysis of association of LRP5, LRP6, SOST, DKK1, and CTNNB1 genes with bone mineral density in a Slovenian population. Calcified Tissue International 2009 85 501-506. (doi:10.1007/s00223-009-9306-y)
8. Yerges LM, Klei L, Cauley JA, Roeder K, Kammerer CM, Ensrud KE, Nestlerode CS, Lewis C, Lang TF, Barrett-Connor E, Moffett SP, Hoffman AR, Ferrell RE, Orwoll ES & Zmuda JM. Candidate gene analysis of femoral neck trabecular and cortical volumetric bone mineral density in older men. Journal of Bone and Mineral Research 2010 25 330-338. (doi:10.1359/jbmr.090729)
9. Olmos JM, Hernandez JL, Martinez J, Pariente E, Llorca J & Gonzalez-Macias J. Bone turnover markers in Spanish adult men: the Camargo Cohort Study. Clinica Chimica Acta 2010 411 19-20. (doi:10.1016/j.cca.2010.06. 010)
10. Lu Y, Fuerst T, Hui S & Genant HK. Standardization of bone mineral density at femoral neck, trochanter and Ward's triangle. Osteoporosis International 2001 12 438-444. (doi:10.1007/s001980170087)
11. Barrett JC, Fry B, Maller J & Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005 21 263-265. (doi:10.1093/bioinformatics/bth457)
12. Conde L, Vaquerizas JM, Dopazo H, Arbiza L, Reumers J, Rousseau F, Schymkowitz J & Dopazo J. PupaSuite: finding functional single nucleotide polymorphisms for large-scale genotyping purposes. Nucleic Acids Research 2006 34 W621-W625. (doi:10.1093/nar/gkl071)
13. Reumers J, Conde L, Medina I, Maurer-Stroh S, Van Durme J, Dopazo J, Rousseau F & Schymkowitz J. Joint annotation of coding and non-coding single nucleotide polymorphisms and mutations in the SNPeffect and PupaSuite databases. Nucleic Acids Research 2008 36 D825-D829. (doi:10.1093/nar/gkm979)
14. Livak KJ & Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(- Delta Delta C(T)) method. Methods 2001 25 402-408. (doi:10.1006/meth.2001.1262)
15. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, Maller J, Sklar P, de Bakker PI, Daly MJ & Sham PC. PLINK: a tool set for whole-genome association and population-based linkage analyses. American Journal of Human Genetics 2007 81 559-575. (doi:10.1086/519795)
16. Pritchard JK, Stephens M & Donnelly P. Inference of population structure using multilocus genotype data. Genetics 2000 155 945-959.
17. Petitti DB. Meta-analysis, Decision Analysis and Cost-effectiveness Analysis. Methods for Quantitative Synthesis in Medicine New York: Oxford University Press, 2000.
18. Bax L, Yu LM, Ikeda N, Tsuruta H & Moons KG. Development and validation of MIX: comprehensive free software for meta-analysis of causal research data. BMC Medical Research Methodology 2006 6 50. (doi:10.1186/1471- 2288-6-50)
19. Nyholt DR. A simple correction for multiple testing for single-nucleotide polymorphisms in linkage disequilibrium with each other. American Journal of Human Genetics 2004 74 765-769. (doi:10.1086/383251)
20. Little RD, Carulli JP, Del Mastro RG, Dupuis J, Osborne M, Folz C, Manning SP, Swain PM, Zhao SC, Eustace B, Lappe MM, Spitzer L, Zweier S, Braunschweiger K, Benchekroun Y, Hu X, Adair R, Chee L, FitzGerald MG, Tulig C, Caruso A, Tzellas N, Bawa A, Franklin B, McGuire S, Nogues X, Gong G, Allen KM, Anisowicz A, Morales AJ, Lomedico PT, Recker SM, Van Eerdewegh P, Recker RR & Johnson ML. A mutation in the LDL receptor-related protein 5 gene results in the autosomal dominant high-bone-mass trait. American Journal of Human Genetics 2002 70 11-19. (doi:10.1086/338450)
21. Balemans W & Van Hul W. The genetics of low-density lipoprotein receptor-related protein 5 in bone: a story of extremes. Endocrinology 2007 148 2622-2629. (doi:10.1210/en.2006-1352)
22. Gong Y, Slee RB, Fukai N, Rawadi G, Roman-Roman S, Reginato AM, Wang H, Cundy T, Glorieux FH, Lev D, Zacharin M, Oexle K, Marcelino J, Suwairi W, Heeger S, Sabatakos G, Apte S, Adkins WN, Allgrove J, Arslan-Kirchner M, Batch JA, Beighton P, Black GC, Boles RG, Boon LM, Borrone C, Brunner HG, Carle GF, Dallapiccola B, de Paepe A, Floege B, Halfhide ML, Hall B, Hennekam RC, Hirose T, Jans A, Juppner H, Kim CA, Keppler-Noreuil K, Kohlschuetter A, Lacombe D, Lambert M, Lemyre E, Letteboer T, Peltonen L, Ramesar RS, Romanengo M, Somer H, Steichen-Gersdorf E, Steinmann B, Sullivan B, Superti-Furga A, Swoboda W, van den Boogaard MJ, Van Hul W, Vikkula M, Votruba M, Zabel B, Garcia T, Baron R, Olsen BR & Warman ML. LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development. Cell 2001 107 513-523. (doi:10.1016/S0092-8674(01) 00571-2)
23. Narumi S, Numakura C, Shiihara T, Seiwa C, Nozaki Y, Yamagata T, Momoi MY, Watanabe Y, Yoshino M, Matsuishi T, Nishi E, Kawame H, Akahane T, Nishimura G, Emi M & Hasegawa T. Various types of LRP5 mutations in four patients with osteoporosis-pseudoglioma syndrome: identification of a 7.2-kb microdeletion using oligonucleotide tiling microarray. American Journal of Medical Genetics 2010 152A 133-140. (doi:10.1002/ajmg.a.33177)
24. Agueda L, Bustamante M, Jurado S, Garcia-Giralt N, Ciria M, Salo G, Carreras R, Nogues X, Mellibovsky L, Diez-Perez A, Grinberg D & Balcells S. A haplotype-based analysis of the LRP5 gene in relation to osteoporosis phenotypes in Spanish post-menopausal women. Journal of Bone and Mineral Research 2008 23 1954-1963. (doi:10.1359/jbmr.080806)
25. Tran BN, Nguyen ND, Eisman JA & Nguyen TV. Association between LRP5 polymorphism and bone mineral density: a Bayesian meta-analysis. BMC Medical Genetics 2008 9 55. (doi:10.1186/1471-2350-9-55)
26. Richards JB, Rivadeneira F, Inouye M, Pastinen TM, Soranzo N, Wilson SG, Andrew T, Falchi M, Gwilliam R, Ahmadi KR, Valdes AM, Arp P, Whittaker P, Verlaan DJ, Jhamai M, Kumanduri V, Moorhouse M, van Meurs JB, Hofman A, Pols HA, Hart D, Zhai G, Kato BS, Mullin BH, Zhang F, Deloukas P, Uitterlinden AG & Spector TD. Bone mineral density, osteoporosis, and osteoporotic fractures: a genome-wide association study. Lancet 2008 371 1505-1512. (doi:10.1016/S0140- 6736(08)60599-1)
27. Styrkarsdottir U, Halldorsson BV, Gretarsdottir S, Gudbjartsson DF, Walters GB, Ingvarsson T, Jonsdottir T, Saemundsdottir J, Center JR, Nguyen TV, Bagger Y, Gulcher JR, Eisman JA, Christiansen C, Sigurdsson G, Kong A, Thorsteinsdottir U & Stefansson K. Multiple genetic loci for bone mineral density and fractures. New England Journal of Medicine 2008 358 2355-2365. (doi:10.1056/NEJMoa0801197)
28. Lee YH,Woo JH, Choi SJ, Ji JD & Song GG. Association between the A1330V polymorphism of the low-density lipoprotein receptor-related protein 5 gene and bone mineral density: a meta-analysis. Rheumatology International 2009 29 539-544. (doi:10.1007/s00296-008-0745-y)
29. van Meurs JB, Trikalinos TA, Ralston SH, Balcells S, Brandi ML, Brixen K, Kiel DP, Langdahl BL, Lips P, Ljunggren O, Lorenc R, Obermayer-Pietsch B, Ohlsson C, Pettersson U, Reid DM, Rousseau F, Scollen S, Van Hul W, Agueda L, Akesson K, Benevolenskaya LI, Ferrari SL, Hallmans G, Hofman A, Husted LB, Kruk M, Kaptoge S, Karasik D, Karlsson MK, Lorentzon M, Masi L, McGuigan FE, Mellstrom D, Mosekilde L, Nogues X, Pols HA, Reeve J, Renner W, Rivadeneira F, van Schoor NM, Weber K, Ioannidis JP & Uitterlinden AG. Large-scale analysis of association between LRP5 and LRP6 variants and osteoporosis. Journal of the American Medical Association 2008 299 1277-1290. (doi:10.1001/jama.299.11.1277)
30. Ferrari SL, Deutsch S, Choudhury U, Chevalley T, Bonjour JP, Dermitzakis ET, Rizzoli R & Antonarakis SE. Polymorphisms in the low-density lipoprotein receptor-related protein 5 (LRP5) gene are associated with variation in vertebral bone mass, vertebral bone size, and stature in whites. American Journal of Human Genetics 2004 74 866-875. (doi:10.1086/420771)
31. Giroux S, Elfassihi L, Cardinal G, Laflamme N & Rousseau F. LRP5 coding polymorphisms influence the variation of peak bone mass in a normal population of French-Canadian women. Bone 2007 40 1299-1307. (doi:10.1016/j.bone.2007.01.004)
32. Brixen K, Beckers S, Peeters A, Piters E, Balemans W, Nielsen TL, Wraae K, Bathum L, Brasen C, Hagen C, Andersen M, Van Hul W & Abrahamsen B. Polymorphisms in the low-density lipoprotein receptor-related protein 5 (LRP5) gene are associated with peak bone mass in non-sedentary men: results from the Odense androgen study. Calcified Tissue International 2007 81 421-429. (doi:10.1007/s00223-007-9088-z)
33. Koay MA, Tobias JH, Leary SD, Steer CD, Vilarino-Guell C & Brown MA. The effect of LRP5 polymorphisms on bone mineral density is apparent in childhood. Calcified Tissue International 2007 81 1-9. (doi:10.1007/s00223-007- 9024-2)
34. Chung BD, Kayserili H, Ai M, Freudenberg J, Uzumcu A, Uyguner O, Bartels CF, Honing S, Ramirez A, Hanisch FG, Nurnberg G, Nurnberg P, Warman ML, Wollnik B, Kubisch C & Netzer C. A mutation in the signal sequence of LRP5 in a family with an osteoporosis-pseudoglioma syndrome (OPPG)-like phenotype indicates a novel disease mechanism for trinucleotide repeats. Human Mutation 2009 30 641-648. (doi:10.1002/humu.20916)
35. Streeten EA, McBride D, Puffenberger E, Hoffman ME, Pollin TI, Donnelly P, Sack P & Morton H. Osteoporosis-pseudoglioma syndrome: description of 9 new cases and beneficial response to bisphosphonates. Bone 2008 43 584-590. (doi:10.1016/j.bone.2008.04.020)
36. Mani A, Radhakrishnan J, Wang H, Mani A, Mani MA, Nelson-Williams C, Carew KS, Mane S, Najmabadi H, Wu D & Lifton RP. LRP6 mutation in a family with early coronary disease and metabolic risk factors. Science 2007 315 1278-1282. (doi:10.1126/science.1136370)
37. Richards JB, Kavvoura FK, Rivadeneira F, Styrkarsdottir U, Estrada K, Halldorsson BV, Hsu YH, Zillikens MC, Wilson SG, Mullin BH, Amin N, Aulchenko YS, Cupples LA, Deloukas P, Demissie S, Hofman A, Kong A, Karasik D, van Meurs JB, Oostra BA, Pols HA, Sigurdsson G, Thorsteinsdottir U, Soranzo N, Williams FM, Zhou Y, Ralston SH, Thorleifsson G, Van Duijn CM, Kiel DP, Stefansson K, Uitterlinden AG, Ioannidis JP & Spector TD. Collaborative meta-analysis: associations of 150 candidate genes with osteoporosis and osteoporotic fracture. Annals of Internal Medicine 2009 151 528-537.